Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients-Reference-Cited by-同舟云学术

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients

Published:2022-02-07 Issue:4 Volume:41 Page:841-850
ISSN:0959-5236
Container-title:Drug and Alcohol Review
language:en
Short-container-title:Drug and Alcohol Review

Author:

Zahra Emma¹^ORCID,Chen Rory¹,Nielsen Suzanne²^ORCID,Tran Anh Dam¹,Santo Thomas¹,Degenhardt Louisa¹^ORCID,Farrell Michael¹,Byrne Jude³,Ali Robert¹⁴,Larance Briony¹⁵⁶^ORCID

Affiliation:

1. National Drug and Alcohol Research Centre UNSW Sydney Sydney Australia

2. Monash Addiction Research Centre Monash University Melbourne Australia

3. Australian Injecting and Illicit Drug Users League Canberra Australia

4. Faculty of Health and Medical Sciences University of Adelaide Adelaide Australia

5. School of Psychology University of Wollongong Wollongong Australia

6. Illawarra Health and Medical Research Institute University of Wollongong Wollongong Australia

Funder

University of New South Wales

Department of Health, Australian Government

National Drug and Alcohol Research Centre

National Institutes of Health

National Health and Medical Research Council

Indivior

Publisher

Wiley

Subject

Health (social science),Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dar.13437

Reference30 articles.

1. Global patterns of opioid use and dependence: harms to populations, interventions, and future action

2. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence;Mattick RP;Cochrane Database Syst Rev,2014

3. World Health Organization. WHO Model List of Essential Medicine. Available at:http://whqlibdoc.who.int/cgi-bin/repository.pl?url=/hq/2005/a87017_eng.pdf;2005.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies;The Lancet Psychiatry;2023-06

2. “You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic;International Journal of Drug Policy;2023-04

3. Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study;Harm Reduction Journal;2023-03-28

4. Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis;Drug and Alcohol Dependence;2023-01

5. Non‐fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study;Medical Journal of Australia;2022-11-07